OMONDI HEALTHCARE LIMITED

	Page
Abridged Balance Sheet	1—2
Notes to the Abridged Financial Statements	3—5

Registered number: 04920144

		2025		2024
	Notes	£	£	£	£
FIXED ASSETS
Tangible Assets	4		27,396		32,370

			27,396		32,370
CURRENT ASSETS
Stocks	5	5,700		9,600
Debtors		179,170		189,185
Investments		35,000		35,000
Cash at bank and in hand		36,218		13,672

		256,088		247,457
Creditors: Amounts Falling Due Within One Year		(187,787 )		(228,282 )

NET CURRENT ASSETS (LIABILITIES)			68,301		19,175

TOTAL ASSETS LESS CURRENT LIABILITIES			95,697		51,545

Creditors: Amounts Falling Due After More Than One Year			-		(12,620 )

NET ASSETS			95,697		38,925

CAPITAL AND RESERVES
Called up share capital	7		100		100
Profit and Loss Account			95,597		38,825

SHAREHOLDERS' FUNDS			95,697		38,925

Page 1

Page 2

OMONDI HEALTHCARE LIMITED

Abridged Balance Sheet (continued)

As At 31 October 2025

For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

All of the company's members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet for the year end 31 October 2025 in accordance with section 444(2A) of the Companies Act 2006.

The financial statements were approved by the board on 24 August 2026 and were signed on its behalf by:

Dr Edmond Edi-Osagie

Director

The notes on pages 3 to 5 form part of these financial statements.

1. General Information

OMONDI HEALTHCARE LIMITED is a private company, limited by shares, incorporated in England & Wales.

The registered number is 04920144 .

The registered office is 74 Dickenson Road, Rusholme, Manchester, M14 5HF.

Dividends paid to the Directors are reported in the notes to the accounts.

Related party transactions are reported in the notes to the accounts.

There are no other related party transactions to report.

There are no contingent liabilities or post balance sheet events to report.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

2.2. Turnover

Turnover represents total invoiced fees for health care services. The business is not Value Added Tax (VAT) registered.

2.3. Tangible Fixed Assets and Depreciation

Tangible fixed assets are stated at cost less accumulated depreciation.

Depreciation is calculated at the following annual rates in order to write off each asset over its estimated useful life.

Plant & Machinery	20% Reducing Balance
Computer Equipment	20% Reducing Balance

No depreciation is charged in the year of acquisition.

2.4. Stocks and Work in Progress

Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.

Work in Progress is valued at the prime cost of labour and materials plus other direct expenses.

2.5. Pensions

The company operates a defined pension contribution scheme. Contributions are charged to the profit and loss account as they become payable in accordance with the rules of the scheme.

2.6. Accounting Reference Date

The accounting reference date is 26 October.

These accounts are nevertheless for the year ended 31 October 2025.

2.7. Comparative Figures

The comparative figures used throughout these accounts are as at 31 October 2024 or are for the year ended on that date.

2.8. Registrar Filing Requirements

The company has taken advantage of Companies Act 2006 section 444(1) and opted not to file the profit and loss account, directors report, and notes to the financial statements relating to the profit and loss account.

3. Average Number of Employees

Average number of employees, including directors, who are employed under a contract of service during the year was as follows:

	2025	2024
Office and administration	3	3

	3	3

Page 3

Page 4

OMONDI HEALTHCARE LIMITED

Notes to the Abridged Financial Statements (continued)

For The Year Ended 31 October 2025

4. Tangible Assets

	Total
	£
Cost
As at 1 November 2024	80,294
Additions	1,500

As at 31 October 2025	81,794

Depreciation
As at 1 November 2024	47,924
Provided during the period	6,474

As at 31 October 2025	54,398

Net Book Value
As at 31 October 2025	27,396

As at 1 November 2024	32,370

5. Stocks

	2025	2024
	£	£
Work in progress	5,700	9,600

6. Secured Creditors

Of the creditors the following amounts are secured.

	2025		2024
	£		£
Bank loans and overdrafts	6,091		11,834

7. Share Capital

	2025	2024
Allotted, called up and fully paid	£	£
500 Ordinary A shares of £ 0.10 each	50	50
500 Ordinary B shares of £ 0.10 each	50	50

	100	100

On 31 March 2024 each £1 Ordinary Share was converted into 10 10p Ordinary Shares.

Dr Edmond Edi-Osagie then owns 500 10p A Ordinary Shares

Dr Edmond Edi-Osagie then owns 275 10p B Ordinary Shares

Dr Ngozi Edi-Osagie then owns 75 10p B Ordinary Shares

8. Pension Commitments

The company operates a defined contribution pension scheme.

The assets of the scheme are held separately from those of the company in an independently administered fund. At the balance sheet date contributions of £Nil (2024 £Nil) were due to the fund and are included in Other Creditors.

Page 4

Page 5

OMONDI HEALTHCARE LIMITED

Notes to the Abridged Financial Statements (continued)

For The Year Ended 31 October 2025

9. Directors Advances, Credits and Guarantees

Included within Debtors are the following loans to directors:

	As at 1 November 2024	Amounts advanced	Amounts repaid	Amounts written off	As at 31 October 2025
	£	£	£	£	£
Dr Edmond Edi-Osagie	134,071	94,500	(83,000 )	-	145,571

The overdrawn loan account is unsecured and repayable on demand.

The loan was subject to interest calculated by reference to the official rate of interest which was 2.25% rising to 3.75% from 6 April 2025.

The amount of interest charged totalled £4,688 (2024 £4,309) and is included in amounts advanced.

The maximum overdrawn balance during the year was £159,916 (2024 £256,064).

10. Related Party Transactions

Associated Companies

ProFertil (UK) Limited is an associated company. For the year ended 31 October 2025, ProFertil (UK) Limited was under the control of the director, Dr Edmond Edi-Osagie, who held 558 £1 Ordinary Shares representing 77.5% of the issued share capital.

Dr Edmond Edi-Osagie was a director of ProFertil(UK) Limited throughout the year.

Charges totalling £Nil (2024 £43,500) were made in the year by ProFertil (UK) Limited for surgical support and assistance and are included in direct costs. The Director reports that charges were set in accordance with open market rates.

Profertil (UK) Limited sold its remaining fixtures and fittings for a consieration of £1,500 following the termination of trade. The Director reports that the price was set in accordance with fair value open market rates.

Transactions in the year with ProFertil (UK) Limited were as follows:

- Balance due from ProFertil (UK) Limited b/f - £Nil (2024 £Nil)

- Monies paid to ProFertil (UK) Limited - £1,500 (2024 £43,500)

- Charges for medical services - £Nil (2024 £43,500)

- Charges for fixtures and fittings - £1,500 (2024 £Nil)

- Balance due from ProFertil (UK) Limited c/f - £Nil (2024 £Nil)

The trade of Profertil (UK) was terminated on 31 October 2024.

11. Ultimate Controlling Party

The Company was controlled by Dr Edmond Edi-Osagie who held 775 10p Ordinary Shares representing 77.5% of the issued share capital.

Page 5